Apotheek A15

What Apotheek A15 does

Apotheek A15 is a GMP-certified pharmaceutical compounding facility headquartered in Gorinchem, Netherlands, producing commercially unavailable but rationally necessary medicines for Dutch hospital pharmacies. Established in 2014 as a collaboration among four Dutch university medical centers (Erasmus MC, UMCG, Radboudumc, and UMCU), the company centralizes sterile, aseptic, and non-sterile preparation that smaller in-hospital pharmacies cannot economically or reliably perform, including tailor-made (magistral) preparations, Ready-to-Use (RTU) and Ready-to-Administer (RTA) products, and investigational compounds for clinical trials.

The core technical asset is approximately 2,000 m² of cleanroom space classified at ISO Class B, C, and D, including aseptic handling rooms and walkable-ceiling designs that allow maintenance without halting production. The facility operates a full pharmaceutical and microbiological quality-control laboratory performing sterility, bioburden, endotoxin, dissolution, disintegration, TOC, GC, and HPLC analyses, supplemented by a climate chamber for stability research. A separate Quality Assurance function manages the validated quality system, product dossiers, audits, and Qualified Person release. The facility opened a new building in October 2022, signaling capacity expansion.

Apotheek A15 runs a sales-led, B2B institutional supply model, distributing compounded preparations and laboratory services directly to hospital pharmacies and the partner UMCs across the Netherlands through negotiated contracts; pricing is not publicly disclosed. Revenue is generated primarily from compounded pharmaceutical supply (sterile, aseptic, non-sterile, stock and magistral preparations) and secondarily from contract analysis (loon-analyse) services. The company is privately held, employee headcount is in the 51–100 range, and no PE/VC ownership or external funding rounds are recorded.

Name

Apotheek A15

Legal name

Apotheek A15

Website

https://apotheeka15.nl

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

Apotheek A15 is a Dutch GMP-certified pharmaceutical compounding facility in Gorinchem producing sterile, aseptic, and non-sterile medicines that are commercially unavailable but rationally necessary. It serves hospital pharmacies nationally as a collaborative initiative of four Dutch university medical centers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Compounding / Hospital Pharmacy Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Hospital & Health-System Pharmacies (Inpatient/Outpatient) (HLAFALAB)

akta.pro secondary industry

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

Keywords

• Pharmaceutical compounding
• Sterile preparations
• Aseptic manufacturing
• Hospital pharmacy supply
• GMP-certified production

Headquarters

HQ city

Gorinchem

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Compounded Pharmaceuticals Supply: Production and supply of compounded pharmaceutical preparations - both stock preparations and magistral preparations - to hospital pharmacies and healthcare institutions. Covers sterile, aseptic, and non-sterile preparations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Apotheek A15 is a state-of-the-art GMP-certified compounding pharmacy in Gorinchem, Netherlands, that produces and supplies commercially unavailable but rationally necessary medicines to hospital pharmacies and healthcare institutions. Its portfolio covers non-sterile, sterile, aseptic, magistral, and Ready-to-Use/Ready-to-Administer (RTU/RTA) preparations, supported by an in-house pharmaceutical and microbiological laboratory that also performs contract analysis (loon-analyse). Operations are organized across four departments: Productie (Production), Laboratorium (Laboratory), Quality Assurance, and Bedrijfsvoering (Business Operations).

Product overview

Apotheek A15 operates as a unified GMP compounding pharmacy platform offering a comprehensive range of pharmaceutical preparations. The core product portfolio includes non-sterile, sterile, and aseptic preparations, with emphasis on Ready to Use (RTU) and Ready to Administer (RTA) products designed to enhance medication safety. The platform also provides magistral (custom) preparations for individual patient needs. Supporting services include a full pharmaceutical quality control laboratory offering contract analysis (loon-analyse) for external clients. The facility maintains approximately 2,000 m² of cleanrooms across class B, C, and D classifications, a complete pharmaceutical and microbiological laboratory, and climate chambers for stability research. Training services for hospital pharmacists are also provided in collaboration with Erasmus MC, UMCG, and Radboudumc.

Differentiator

Problem solved

Functional benefit

Products and services

• Non-Sterile Preparations Non-sterile compounded pharmaceutical preparations produced for hospital pharmacies and healthcare institutions for medicines not commercially available but rationally necessary for patient care.
• Sterile Preparations Sterile pharmaceutical preparations manufactured in ISO-classified cleanrooms for safe administration to patients, supplied to hospital pharmacies.
• Aseptic Preparations Aseptic compounding services including individual and stock aseptic manipulations, produced in Class B cleanroom environments, supplied to hospital pharmacies.
• Ready to Use (RTU) Products Pre-prepared sterile pharmaceutical products ready for immediate use, supplied to hospital pharmacies to improve medication safety.
• Ready to Administer (RTA) Products Pharmaceutical products prepared and packaged for direct administration to patients, supplied to hospital pharmacies to minimize preparation errors.
• Magistral Preparations Custom-made medications prepared according to individual prescriptions for patients when commercially unavailable options exist.
• Contract Analysis Services (Loon-analyse) Pharmaceutical quality control and analytical testing services, including microbiological (sterility, bioburden, endotoxin) and chemical (dissolution, disintegration, TOC, GC, HPLC) analyses performed on a contract basis for external clients.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Erasmus MCcoreStrategic or Co-development PartnerFounding partner and collaborator in Apotheek A15, contributing expertise and support for pharmaceutical compounding operations and pharmacist training.
• Universitair Medisch Centrum Groningen (UMCG)coreStrategic or Co-development PartnerFounding partner and collaborator in Apotheek A15, contributing expertise and support for pharmaceutical compounding operations and pharmacist training.
• RadboudumccoreStrategic or Co-development PartnerFounding partner and collaborator in Apotheek A15, contributing expertise and support for pharmaceutical compounding operations and pharmacist training.
• Universitair Medisch Centrum Utrecht (UMCU)coreStrategic or Co-development PartnerFounding partner and collaborator in Apotheek A15, contributing expertise and support for pharmaceutical compounding operations and pharmacist training.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Catalent: Global CDMO with broad pharmaceutical manufacturing capabilities including sterile fill-finish. Comparable as a large-scale incumbent providing outsourced pharmaceutical manufacturing services including sterile preparations.
• Recipharm: European pharmaceutical CDMO offering contract manufacturing and development services. Comparable as a broad pharmaceutical services incumbent serving European pharma customers with GMP manufacturing capabilities.
• B. Braun Melsungen: Global medical technology and pharmaceutical company with hospital pharmacy compounding and sterile preparation services. Comparable as a much larger incumbent offering overlapping sterile/aseptic preparation services to hospitals.
• Baxter International: Global healthcare company with significant sterile injectable and prepared solution manufacturing operations. Comparable as a large incumbent producing ready-to-administer hospital pharmaceuticals at industrial scale.

Direct peers

• NextPharma: European pharmaceutical CDMO offering contract development and manufacturing across multiple dosage forms. Comparable as a European-focused GMP manufacturer serving pharma customers with specialized production capabilities.
• Fagron: Global leader in pharmaceutical compounding headquartered in Belgium/Netherlands. Directly comparable as both organizations focus on preparing patient-specific and commercially unavailable pharmaceutical preparations under strict quality standards.
• Hovione: Portugal-headquartered CDMO with strong European presence in pharmaceutical development and manufacturing. Comparable as a mid-sized specialized pharmaceutical manufacturer serving institutional customers with GMP-grade production.
• Clinigen Group: UK-headquartered specialty pharmaceutical services company providing unlicensed and difficult-to-source medicines to hospitals. Highly comparable business model serving the same unmet-medicine niche across European hospitals.
• Tiofarma: Dutch pharmaceutical CDMO based in Oud-Beijerland providing contract manufacturing and compounding services. Comparable business model serving pharmaceutical customers with GMP manufacturing capabilities in the Netherlands.

Others

• Eurofins Scientific: Global testing services provider with extensive pharmaceutical and microbiological laboratory capabilities. Comparable as an adjacent ecosystem participant offering contract analytical services similar to Apotheek A15's loon-analyse offering.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/apotheek-a15

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Apotheek A15